Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Bayer and Tsinghua University to Form Joint Institute

publication date: Mar 19, 2009

Bayer HealthCare AG of Germany has signed a wide-ranging collaboration agreement with Beijing’s Tsinghua University. The two entities will establish the Bayer-Tsinghua (Institute of Biomedicine) Research Center of Innovative Drug Discovery. Serving as Director will be Yigong Shi, PhD, a renowned structural biologist with expertise in protein X-ray crystallography and a focus on apoptosis. Dr. Shi is currently Director of the Department of Biological Sciences and Biotechnology and Vice Dean of the Institute of Biomedicine of Tsinghua University. More details...

Stock Symbol: (Frankfurt: SCH)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here